Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

Author: 
Parker C. [etal]
Publisher: 
New England Journal of Medicine
Date published: 
2013
Record type: 
Journal Title: 
The New England Journal of Medicine
Source: 
The New England Journal of Medicine, Vol. 369, No. 3, July 18, 2013, pp. 213-223
Subject: 
Abstract: 

In a study involving men with castration-resistant prostate cancer and bone metastases, the alpha emitter radium-223 significantly prolonged survival, as compared with placebo, and was associated with fewer adverse events.

Language: 

CITATION: Parker C. [etal]. Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer . : New England Journal of Medicine , 2013. The New England Journal of Medicine, Vol. 369, No. 3, July 18, 2013, pp. 213-223 - Available at: https://library.au.int/alpha-emitter-radium-223-and-survival-metastatic-prostate-cancer-4